Anti-PIGR monoclonal antibody

Anti-PIGR antibody for FACS & in-vivo assay

Target products collectionGo to PIGR/PIGR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1368-Ab-1/ GM-Tg-hg-MP1368-Ab-2Anti-Human PIGR monoclonal antibodyHuman
GM-Tg-rg-MP1368-Ab-1/ GM-Tg-rg-MP1368-Ab-2Anti-Rat PIGR monoclonal antibodyRat
GM-Tg-mg-MP1368-Ab-1/ GM-Tg-mg-MP1368-Ab-2Anti-Mouse PIGR monoclonal antibodyMouse
GM-Tg-cynog-MP1368-Ab-1/ GM-Tg-cynog-MP1368-Ab-2Anti-Cynomolgus/ Rhesus macaque PIGR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1368-Ab-1/ GM-Tg-felg-MP1368-Ab-2Anti-Feline PIGR monoclonal antibodyFeline
GM-Tg-cang-MP1368-Ab-1/ GM-Tg-cang-MP1368-Ab-2Anti-Canine PIGR monoclonal antibodyCanine
GM-Tg-bovg-MP1368-Ab-1/ GM-Tg-bovg-MP1368-Ab-2Anti-Bovine PIGR monoclonal antibodyBovine
GM-Tg-equg-MP1368-Ab-1/ GM-Tg-equg-MP1368-Ab-2Anti-Equine PIGR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1368-Ab-1/ GM-Tg-hg-MP1368-Ab-2; GM-Tg-rg-MP1368-Ab-1/ GM-Tg-rg-MP1368-Ab-2;
GM-Tg-mg-MP1368-Ab-1/ GM-Tg-mg-MP1368-Ab-2; GM-Tg-cynog-MP1368-Ab-1/ GM-Tg-cynog-MP1368-Ab-2;
GM-Tg-felg-MP1368-Ab-1/ GM-Tg-felg-MP1368-Ab-2; GM-Tg-cang-MP1368-Ab-1/ GM-Tg-cang-MP1368-Ab-2;
GM-Tg-bovg-MP1368-Ab-1/ GM-Tg-bovg-MP1368-Ab-2; GM-Tg-equg-MP1368-Ab-1/ GM-Tg-equg-MP1368-Ab-2
Products NameAnti-PIGR monoclonal antibody
Formatmab
Target NamePIGR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PIGR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PIGR VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1368
    Target NamePIGR
    Gene ID5284,18703,25046,694638,474357,101090323,281401,100055765
    Gene Symbol and SynonymspIgA-R,PIGR,RNPIGR2
    Uniprot AccessionP01833,P15083,P81265
    Uniprot Entry NamePIGR_HUMAN,PIGR_RAT,PIGR_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseDiabetic Nephropathy, Dent disease
    Gene EnsemblENSG00000162896
    Target ClassificationN/A

    The target: PIGR, gene name: PIGR, also named as . This gene is a member of the immunoglobulin superfamily. The encoded poly-Ig receptor binds polymeric immunoglobulin molecules at the basolateral surface of epithelial cells; the complex is then transported across the cell to be secreted at the apical surface. A significant association was found between immunoglobulin A nephropathy and several SNPs in this gene.[provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.